$ESSI

ECO SCIENCE SOLUTIONS, INC.

CIK:0001490873|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
Revenue	$ 1,952	$ 0	$ 2,205	$ 0
Total revenue	1,952	0	2,205	0
Operating expenses:
Amortization	8,333	0	13,889	0
Legal, accounting and audit fees	23,808	20,331	54,617	37,790
Management and consulting fees	122,500	125,500	245,000	251,000
Research, development, and promotion	78,705	80,053	140,738	178,770
Office supplies and other general expenses	14,420	17,014	26,004	29,633
Total operating expenses	247,766	242,898	480,248	497,193
Net operating loss	(245,814)	(242,898)	(478,043)	(497,193)
Other income (expenses)
Interest expense	(10,500)	(9,807)	(21,048)	(19,295)
Interest expense, related parties	0	(10,138)	0	(19,776)
Total other income (expenses)	(10,500)	(19,945)	(21,048)	(39,071)
Net loss	$ (256,314)	$ (262,843)	$ (499,091)	$ (536,264)
Net loss per common share - basic and diluted	$ (0.01)	$ (0.12)	$ (0.02)	$ (0.25)
Weighted average common shares outstanding - basic and diluted	24,952,656	2,118,303	24,952,656	2,118,303

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025
Cash flows from operating activities:
Net income (loss)	$ (499,091)	$ (536,264)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Amortization	13,889	0
Changes in operating assets and liabilities:
Prepaid expenses	36,250	2,970
Accounts Receivable	(1,797)	0
Customer deposits	7,442	0
Increase in accounts payable and accrued expenses	125,629	215,745
Increase in related party payables	300,530	155,067
Net cash used in operating activities	(17,148)	(162,482)
Cash Flows from Investing Activities:
Net cash used in investing activities	0	0
Cash flows from financing activities:
Advances from related party loans	0	162,763
Net cash provided by financing activities	0	162,763
Net increase (decrease) in cash	(17,148)	281
Cash-beginning of period	32,699	2,817
Cash-end of period	15,551	3,098
SUPPLEMENTAL DISCLOSURES
Interest paid	0	0
Income taxes paid	$ 0	$ 0

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jul. 31, 2026	Jan. 31, 2026
Current assets
Cash	$ 15,551	$ 32,699
Accounts receivable	1,797	0
Prepaid expenses	1,875	38,125
Total current assets	19,223	70,824
Intangible asset, net	86,111	100,000
TOTAL ASSETS	105,334	170,824
Current liabilities
Accounts payable and accrued expenses	1,015,417	889,788
Related party payable	300,530	0
Customer deposits	7,442	0
Notes payable	350,000	350,000
Total current liabilities	1,673,389	1,239,788
Total liabilities	1,673,389	1,239,788
Commitments and contingencies	0	0
Stockholders' deficit
Preferred stock, $0.001 par, 50,000,000 shares authorized of which 1,000 shares are designated Series A Voting Preferred, none issued and outstanding	0	0
Common stock, $0.0001 par, 650,000,000 shares authorized, 24,992,656 shares issued and 24,952,656 shares outstanding	2,499	2,499
Treasury stock (40,000 shares issued at a cost of $0.1875 per share)	(7,500)	(7,500)
Additional paid in capital	68,220,090	68,220,090
Accumulated deficit	(69,783,144)	(69,284,053)
Total stockholders' deficit	(1,568,055)	(1,068,964)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 105,334	$ 170,824